Autopsy and Case Reports
https://autopsyandcasereports.org/article/doi/10.4322/acr.2016.048
Autopsy and Case Reports
Article / Clinical Case Report

Unmasking histoplasmosis immune reconstitution inflammatory syndrome in a patient recently started on antiretroviral therapy

Reuben Kiggundu, Henry W Nabeta, Richard Okia, Joshua Rhein, Robert Lukande

Downloads: 31
Views: 767

Abstract

Histoplasmosis is the most common endemic mycoses among HIV-infected people. Patients with suppressed cell immunity mainly due to HIV are at increased risk of disseminated disease. Dermatological manifestations of immune reconstitution inflammatory syndrome (IRIS) and cutaneous manifestations of histoplasmosis similar to an IRIS event have been previously described. We report the case of a 43-year-old male who presented with cutaneous disseminated histoplasmosis due to Histoplasma capsulatum var. capsulatum 4 months after the onset of the antiretroviral therapy and some improvement in the immune reconstitution. After 2 weeks of amphotericin B and itraconazole therapy, the scheduled treatment involved fluconazole maintenance therapy, which resulted in an improvement of his skin lesions.

Keywords

Histoplasmosis, Immune Reconstitution Inflammatory Syndrome, Antiretroviral Therapy, Highly Active, Fluconazole

References

1. Wheat LJ. Histoplasmosis: a review for clinicians from non-endemic areas. Mycoses. 2006;49(4):274-82. http://dx.doi.org/10.1111/j.1439-0507.2006.01253.x. PMid:16784440.

2. Cottle LE, Gkrania-Klotsas E, Williams HJ, et al. A multinational outbreak of histoplasmosis following a biology field trip in the Ugandan rainforest. J Travel Med. 2013;20(2):83-7. http://dx.doi.org/10.1111/jtm.12012. PMid:23464714.

3. Regional T, Unit R, Helier S. Caecal perforation in a renal transplant patient with disseminated histoplasmosis. 1988;41(9):992-5. PMID: 3056989.

4. Kurowski R, Ostapchuk M. Overview of histoplasmosis. Am Fam Physician. 2002;66(12):2247-52. PMid:12507161.

5. Kauffman CA. Histoplasmosis: a clinical and laboratory update. Clin Microbiol Rev. 2007;20(1):115-32. http://dx.doi.org/10.1128/CMR.00027-06. PMid:17223625.

6. Pervez MM, Cobb B, Matin N, Shahrin L, Ford ER, Pietroni M. Disseminated histoplasmosis in a patient with advanced HIV disease-lessons learnt from Bangladesh. J Health Popul Nutr. 2010;28(3):305-7. http://dx.doi.org/10.3329/jhpn.v28i3.5561. PMid:20635643.

7. Gutierrez ME, Canton A, Sosa N, Puga E, Talavera L. Disseminated histoplasmosis in patients with AIDS in Panama: a review of 104 cases. Clin Infect Dis. 2005;40(8):1199-202. http://dx.doi.org/10.1086/428842. PMid:15791523.

8. Wheat LJ, Chetchotisakd P, Williams B, Connolly P, Shutt K, Hajjeh R. Factors associated with severe manifestations of histoplasmosis in AIDS. Clin Infect Dis. 2000;30(6):877-81. http://dx.doi.org/10.1086/313824. PMid:10854363.

9. Lehloenya R, Meintjes G. Dermatologic manifestations of the immune reconstitution inflammatory syndrome. Dermatol Clin. 2006;24(4):549-70. http://dx.doi.org/10.1016/j.det.2006.06.007. PMid:17010783.

10. Amerson EH, Maurer TA. Immune reconstitution inflammatory syndrome and tropical dermatoses. Dermatol Clin. 2011;29(1):39-43. http://dx.doi.org/10.1016/j.det.2010.09.007. PMid:21095526.

11. Centers for Disease Control – CDC. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases. MMWR Suppl. 1987;36(1):1S-15S. PMID: 3039334.

12. Loulergue P, Bastides F, Baudouin V, et al. Literature review and case histories of Histoplasma capsulatum var. dubloisii infections in HIV-infected patients. Emerg Infect Dis. 2007;13(11):1647-52. PMid:18217546.

13. Gugnani HC. Histoplasmosis in Africa: a review. Indian J Chest Dis Allied Sci. 2000;42(4):271-7. PMid:15597674.

14. Chaturvedi S, Frame P, Newman SL. Macrophages from human immunodeficiency virus-positive persons are defective in host defense against Histoplasma capsulatum. J Infect Dis. 1995;171(2):320-7. PMID: 7844367.

15. Wheat LJ, Freifeld AG, Kleiman MB, et al. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007;45(7):807-25. http://dx.doi.org/10.1086/521259. PMid:17806045.

16. Bradsher RW. Histoplasmosis and blastomycosis. Clin Infect Dis. 1996;22(Suppl 2):S102-11. PMid:8722836.

17. Kahi CJ, Wheat LJ, Allen SD, Sarosi GA. Gastrointestinal histoplasmosis. Am J Gastroenterol. 2005;100(1):220-31. http://dx.doi.org/10.1111/j.1572-0241.2005.40823.x. PMid:15654803.

18. Verma SB. Chronic disseminated cutaneous histoplasmosis in an immunocompetent individual - a case report. Int J Dermatol. 2006;45(5):573-6. http://dx.doi.org/10.1111/j.1365-4632.2006.02762.x. PMid:16700795.

19. Delfino E, di Biagio A, Chandrapatham K, Viscoli C, Prinapori R. Disseminated histoplasmosis with mucocutaneous immune reconstitution inflammatory syndrome in an HIV-infected patient. AIDS Res HumRetroviruses. 2015;31(3):274-5. http://dx.doi.org/10.1089/aid.2014.0329. PMid:25723353.

20. Nacher M, Sarazin F, El Guedj M, et al. Increased incidence of disseminated histoplasmosis following highly active antiretroviral therapy initiation. J Acquir Immune Defic Syndr. 2006;41(4):468-70. http://dx.doi.org/10.1097/01.qai.0000209927.49656.8d. PMid:16652055.

21. Passos L, Talhari C, Santos M, Ribeiro-Rodrigues R, Ferreira LC, Talnari S. Histoplasmosis-associated immune reconstitution inflammatory syndrome. An Bras Dermatol. 2011;86(4 Suppl 1):S168-72. http://dx.doi.org/10.1590/S0365-05962011000700044. PMid:22068802.

22. Breton G, Adle-Biassette H, Therby A, et al. Immune reconstitution inflammatory syndrome in HIV-infected patients with disseminated histoplasmosis. AIDS. 2006;20(1):119-21. http://dx.doi.org/10.1097/01.aids.0000199014.66139.39. PMid:16327328.

23. Haddow LJ, Easterbrook PJ, Mosam A, et al. Defining immune reconstitution inflammatory syndrome: evaluation of expert opinion versus 2 case definitions in a South African cohort. Clin Infect Dis. 2009;49(9):1424-32. http://dx.doi.org/10.1086/630208. PMid:19788360.

24. Robertson J, Meier M, Wall J, Ying J, Fichtenbaum CJ. Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy. Clin Infect Dis. 2006;42(11):1639-46. http://dx.doi.org/10.1086/503903. PMid:16652323.

25. Gómez BL, Figueroa JI, Hamilton AJ, et al. Detection of the 70-kilodalton Histoplasma capsulatum antigen in serum of histoplasmosis patients: correlation between antigenemia and therapy during follow-up. J Clin Microbiol. 1999;37(3):675-80. PMid:9986830.

26. Durkin MM, Connolly PA, Wheat LJ. Comparison of radioimmunoassay and enzyme-linked immunoassay methods for detection of Histoplasma capsulatum var. capsulatum Antigen. J Clin Microbiol. 1997;35(9):2252-5. PMid:9276396.

27. Gomez BL, Figueroa JI, Hamilton AJ, et al. Development of a novel antigen detection test for histoplasmosis. J Clin Microbiol. 1997;35(10):2618-22. PMid:9316918.

28. Murata M, Furusyo N, Otaguro S, Nabeshima S, Ariyama I, Hayashi J. HIV infection with concomitant cerebral toxoplasmosis and disseminated histoplasmosis in a 45-year-old man. J Infect Chemother. 2007;13(1):51-5. http://dx.doi.org/10.1007/s10156-006-0486-3. PMid:17334730.

29. Wheat J, Hafner R, Korzun AH, et al. Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. Am J Med. 1995;98(4):336-42. http://dx.doi.org/10.1016/S0002-9343(99)80311-8. PMid:7709945.

30. Wheat LJ, Connolly P, Smedema M, Brizendine E, Hafner R. Emergence of resistance to fluconazole as a cause of failure during treatment of histoplasmosis in patients with acquired immunodeficiency disease syndrome. Clin Infect Dis. 2001;33(11):1910-3. http://dx.doi.org/10.1086/323781. PMid:11692303.

31. Wheat J, Marichal P, Vanden Bossche H, Le Monte A, Connolly P. Hypothesis on the mechanism of resistance to fluconazole in Histoplasma capsulatum. Antimicrob Agents Chemother. 1997;41(2):410-4. PMid:9021199.

32. Goldman M, Zackin R, Fichtenbaum CJ, et al. Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy. Clin Infect Dis. 2004;38(10):1485-9. http://dx.doi.org/10.1086/420749. PMid:15156489.

33. Agudelo CA, Rosero DS, Ochoa JE, et al. Disseminated Histoplasmosis: a comparative study between patients with acquired immunodeficiency syndrome and non-human immunodeficiency virus – infected individuals. Am Soc Trop Med Hyg. 2005;73(3):576-82. PMid:16172484.

34. Jenny-Avital E. Successful discontinuation of high-dose fluconazole for Histoplasma capsulatum meningitis in an AIDS Patient after sustained immune reconstitution. J Chem Inf Model. 2004;39(8):1261-2. http://dx.doi.org/10.1086/424753. PMID: 15486865.


Publication date:
12/12/2016

584ead2d0e88254a4a4fbaad autopsy Articles
Links & Downloads

Autops Case Rep

Share this page
Page Sections